H|T: The Healthtech Times H|T: The Healthtech Times – Virtual therapists
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!
H|T: The Healthtech Times H|T: The Healthtech Times – The next tech battleground
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!
Kitchener-Waterloo healthtech startup Nicoya said it is set to receive more financial support from the Government of Canada to develop its COVID-19 test, Atlas.
Share this article
Share this article
KITCHENER, Ontario, April 6, 2021 /PRNewswire/ Nicoya Lifesciences, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, is pleased to announce that it is receiving additional advisory services and funding to continue research and development of its rapid, saliva-based COVID-19 antigen test. This is the second phase of support from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). As part of a joint challenge issued with the Public Health Agency of Canada (PHAC) through the government s Innovative Solutions Canada (ISC) program, the funding could reach up to $1,998,592. To date, the company has received $299,190 in funding and advisory services from NRC IRAP under Phase I of the challenge.